MediWound To Raise $100M On Nasdaq

November 26, 2013 | Israeli biomed company MediWound, which develops advanced treatments for wounds and burns, is planning to hold an IPO on Nasdaq. “Calcalist” reports that the company is planning to hold the offering at a company value of $500 million and will offer shares worth $100 million. The IPO is set to take place in Q2, 2014.